Agreed Samsa, it's a preliminary prospectus which IPCI's trying to get the SEC to approve...so right now that .455 strike price was just used to calculate the potential registration fees if the SEC approves...and now we have to wait for the SEC to approve the registration and once they do, IPCI will only receive new funding from the warrants if the share prices rise above .60 cents per share(lowest warrants strike price unless the warrants strike price gets drastically lowered upon registration) ahead of the now fast approaching reverse split next month.
So I highly doubt IPCI will raise any new monies from registering the warrants with the R/S vote looming in 26 days unless the warrants strike prices get drastically lowered upon the SEC approving the registration...and no miracle positive catalysts that we know of en route ahead of the Aug 15th shareholder proxy vote.
Also of interesting note, this prospectus clearly states that all we're voting on on August 15th is mgmt.'s proposed reverse split...so why the hell they selected the June 28th Shareholders Of Record date to be included on the reverse split vote is beyond me.
All in all I see nothing positive occurring here. All I see is the r/s getting approved on august 15th, then IPCI immediately doing another dilutive offering post reverse split and the share price eroding in the post reverse split era due to dilution.
This company couldn't even be bothered putting out a Press Release informing the market that the CAT 2 & 3 oral studies had begun on their Oxycontin NDA candidate sometime over the past several weeks despite their stock being in the gutter...so IMO only there's no miracle positive solutions coming despite Boyd's probable influence on mgmt...if there was, at the very least IPCI mgmt. would already be taking drastic steps to vastly improve their pathetic market image which they're definitely not doing glta>>>
News 
Market Data 
Discover 
AI
